Popliteal Sciatic Nerve Block

Quick Answer

Popliteal sciatic nerve block targets the sciatic nerve in the popliteal fossa before or at its division into tibial and common peroneal nerves, providing anesthesia to the entire foot, ankle, and lower leg below the knee (except the medial strip supplied by saphenous nerve). Indications: Foot and ankle surgery, distal tibia/fibula procedures, Achilles tendon repair, triple arthrodesis, ankle fractures. Technique: Ultrasound-guided - probe transverse 5-10 cm proximal to popliteal crease, identify popliteal artery (deep, pulsatile), tibial nerve (superficial to artery), and common peroneal nerve (lateral); in-plane approach from lateral to medial, deposit 15-20 mL beneath nerve. Critical: Block above the nerve bifurcation (5-10 cm proximal to crease) to anesthetize both branches with single injection. Sensory coverage: Plantar foot (tibial), dorsal foot (common peroneal), lateral leg, posterior leg. Combine with: Saphenous/adductor canal block for complete foot coverage. Duration: 8-14 hours (ropivacaine 0.5%) or 10-18 hours (bupivacaine 0.375-0.5%). Success rate: 95-98% with ultrasound. [1-20]

Anatomy

Popliteal Fossa Boundaries and Contents

Anatomical Boundaries:

The popliteal fossa is a diamond-shaped space posterior to the knee joint containing the neurovascular structures supplying the lower leg and foot.

Superior Border:

• Laterally: Tendon of biceps femoris muscle (extends from ischial tuberosity to fibular head)
• Medially: Tendons of semimembranosus (posterior medial tibial condyle) and semitendinosus (medial to semimembranosus)
• Roof: Skin, superficial fascia containing small saphenous vein and sural nerve, deep popliteal fascia

Inferior Border:

• Two heads of gastrocnemius muscle: Medial and lateral heads form inferior boundary
• Floor: Posterior knee joint capsule, popliteal surface of femur, fascia over popliteus muscle

Contents (from superficial to deep):

1. Tibial nerve: Most superficial structure in neurovascular bundle
2. Common peroneal nerve: Lateral and slightly superficial, often diverging proximally
3. Popliteal vein: Medial to artery, often partially compressed
4. Popliteal artery: Deepest structure, central position

Popliteal Artery:

• Continuation: Of femoral artery at adductor hiatus (opening in adductor magnus)
• Course: Deep through popliteal fossa, giving genicular branches to knee
• Termination: Divides into anterior and posterior tibial arteries at lower border of popliteus muscle
• Characteristics: Pulsatile, thick-walled, round or slightly oval on ultrasound

Popliteal Vein:

• Position: Superficial and slightly medial to artery
• Characteristics: Thin-walled, compressible, often oval/collapsed in supine position
• Tributaries: Small saphenous vein (penetrates deep fascia at mid-calf)

Sciatic Nerve Terminal Branches

Sciatic Nerve Course and Division:

The sciatic nerve (L4-S3) enters the thigh posteriorly and courses between the hamstring muscles (biceps femoris laterally, semimembranosus/semitendinosus medially) toward the popliteal fossa. The nerve typically divides into its two terminal branches 4-10 cm proximal to the popliteal skin crease, though this is highly variable:

Variation in Division Point:

• High division (rare): 10-15 cm proximal to crease (near mid-thigh)
• Standard division: 5-8 cm proximal to crease
• Low division: 2-5 cm proximal to crease
• Within popliteal fossa: Some individuals have nerve remain undivided until deep in fossa
• Pre-division (rare): Division within pelvis or gluteal region

Clinical Significance:

• Injection must be proximal to bifurcation to block both branches with single injection
• If nerves already divided, may need separate blocks for tibial and common peroneal
• Always scan proximally to identify nerve confluence

Tibial Nerve (L4-S3):

• Origin: Medial component of sciatic nerve
• Course: Continues deep through popliteal fossa, passes between heads of gastrocnemius
• Terminal branches:
  • Medial plantar nerve (medial sole, 3.5 toes)
  • Lateral plantar nerve (lateral sole, 1.5 toes)
  • Sural nerve (posterior lateral leg, lateral foot)
• Motor: Posterior leg compartment (gastrocnemius, soleus, plantaris, popliteus, tibialis posterior, flexor digitorum longus, flexor hallucis longus) - plantarflexion, toe flexion
• Sensory: Posterior leg, lateral ankle/heel, plantar foot, toes (except first web space)

Common Peroneal Nerve (L4-S2):

• Origin: Lateral component of sciatic nerve
• Course: Travels laterally along biceps femoris tendon, then passes superficial to lateral head of gastrocnemius, winds around neck of fibula
• Terminal branches:
  • Deep peroneal nerve: First web space (dorsal), anterior compartment muscles (dorsiflexion)
  • Superficial peroneal nerve: Lateral/anterior leg, dorsal foot (except first web space)
  • Articular branches: Knee joint
• Motor: Anterior leg compartment (tibialis anterior, extensor digitorum longus, extensor hallucis longus, peroneus tertius) - dorsiflexion; Lateral compartment (peroneus longus/brevis) - eversion
• Sensory: Lateral leg, dorsal foot (except first web space and lateral border)

Sural Nerve:

• Origin: Medial sural cutaneous nerve (tibial) + lateral sural cutaneous nerve (common peroneal)
• Course: Posterior leg, lateral to midline, passes lateral to Achilles tendon
• Sensory: Posterior lateral leg, lateral margin of foot and little toe
• Note: Usually blocked with popliteal approach, but variable contribution

Ultrasound Anatomy

Probe Position and Initial Scan:

Probe Type:

• High-frequency linear (10-15 MHz): Standard for most patients
• Curved array (5-8 MHz): For obese patients or if imaging >6-8 cm depth

Probe Orientation:

• Transverse: Perpendicular to nerve/vessel course
• Position: 5-10 cm proximal to popliteal skin crease
• Pressure: Moderate to compress vein, improve nerve visualization

Layer-by-Layer Sonographic Appearance:

Superficial (Nearest Probe):

1. Skin and subcutaneous tissue: Hyperechoic line (skin), hypoechoic fat
2. Popliteal fascia: Hyperechoic linear structure
3. Sural nerve: Small, round, hyperechoic (variable, lateral)

Intermediate: 4. Tibial nerve: Large (sciatic is largest peripheral nerve), hyperechoic, round or oval, "honeycomb" internal structure 5. Common peroneal nerve: Smaller than tibial, lateral, often diverging proximally, hyperechoic 6. Popliteal vein: Medial to artery, thin-walled, anechoic (black), easily compressible

Deep: 7. Popliteal artery: Round/oval, anechoic, pulsatile, thick walls, non-compressible 8. Bony structures: Femoral condyles (posterior) - hyperechoic with acoustic shadowing

Muscle Borders:

• Superior lateral: Biceps femoris (tendon or muscle)
• Superior medial: Semimembranosus/semitendinosus
• Inferior: Gastrocnemius heads

Nerve Dynamics:

• Probe pressure: Nerve may flatten or move (especially if inflammation/scarring)
• Ankle flexion/extension: Can help identify nerve (moves with tendon motion)
• Vessel pulsation: Arterial pulsation helps distinguish from nerve

Key Identification Tips:

1. Find artery first: Most consistent landmark, pulsatile, non-compressible
2. Nerve is superficial to artery: Tibial nerve directly above vessels
3. Common peroneal is lateral: Often seen diverging
4. Trace proximally: Follow nerves cephalad to find where they join (optimal injection site)
5. Dynamic assessment: Slight leg movement helps distinguish nerve from tendons

Fascial Relations

Popliteal Fascia:

• Superficial layer: Thin fascia under skin, continuous with deep fascia of thigh
• Deep layer: Dense fascia forming roof of popliteal fossa
• Significance: Local anaesthetic must penetrate this fascia to reach nerve

Neurovascular Sheath:

• Not true fascial compartment: Unlike axillary sheath, popliteal neurovascular structures not contained in tight fascia
• Spread pattern: Local anaesthetic spreads along tissue planes around nerve
• Optimal injection: Beneath nerve (between nerve and artery) produces circumferential spread

Hamstring Tendons:

• Biceps femoris tendon: Lateral, may be confused with common peroneal nerve
  • Tendon: Fibrillar, hyperechoic, anisotropic (disappears if probe tilted)
  • Nerve: Honeycomb, remains visible with probe tilt
• Semimembranosus/semitendinosus tendons: Medial, posterior to vessels

Sensory Distribution

Popliteal Block Provides Anesthesia To:

Foot:

• Plantar surface: Entire sole (tibial nerve - medial and lateral plantar nerves)
• Dorsal surface: Entire dorsum except lateral margin and first web space
  • First web space: Deep peroneal nerve (common peroneal branch)
  • Remainder of dorsum: Superficial peroneal nerve (common peroneal branch)
  • Lateral margin: Sural nerve (tibial branch contribution)

Ankle:

• Posterior ankle/heel: Tibial nerve, sural nerve
• Lateral ankle: Sural nerve, superficial peroneal
• Anterior ankle: Deep peroneal, superficial peroneal
• Medial ankle: NOT blocked (requires saphenous nerve block)

Lower Leg:

• Posterior leg: Tibial nerve (sural branch)
• Lateral leg: Sural nerve, superficial peroneal
• Anterior leg: Deep peroneal, superficial peroneal
• Medial leg: NOT blocked (saphenous nerve territory)

Knee:

• Posterior knee joint: Tibial nerve articular branches
• Lateral knee: Common peroneal articular branches
• Medial/anterior knee: NOT blocked (femoral/obturator/saphenous)

Complete Foot/Ankle Anesthesia Requires:

• Popliteal sciatic block (above) + Saphenous nerve block (medial coverage)

Indications and Contraindications

Indications

Surgical Procedures:

Foot Surgery:

• Ankle fracture ORIF (open reduction internal fixation)
• Triple arthrodesis (subtalar, talonavicular, calcaneocuboid fusion)
• Bunionectomy/hallux valgus correction
• Toe amputations
• Forefoot reconstruction
• Plantar fascia release
• Tarsal tunnel release
• Neuroma excision
• Soft tissue tumor excision

Ankle Surgery:

• Ankle arthroscopy
• Achilles tendon repair
• Ankle ligament repair
• Ankle fusion
• Tendo-Achilles lengthening

Lower Leg Surgery:

• Distal tibia fracture fixation
• Distal fibula fracture fixation
• Fasciotomy for compartment syndrome
• Soft tissue debridement
• Skin grafting

Combined Procedures:

• With saphenous block: Complete lower limb below knee
• With femoral block: Complete lower limb above and below knee
• For knee surgery (hamstring harvest): Popliteal block provides analgesia to posterior structures

Pain Management:

• Acute pain: Postoperative analgesia following foot/ankle surgery
• Chronic pain: Complex regional pain syndrome (CRPS) type I/II of foot
• Trauma: Analgesia for ankle/foot fractures in emergency department
• Cancer pain: Foot malignancy palliation

Specific Advantages:

• Outpatient suitability: Single-shot block facilitates same-day discharge
• Opioid sparing: Reduces postoperative opioid requirements
• Prolonged analgesia: 12-18 hours with long-acting local anaesthetics
• Catheter capability: Excellent site for continuous infusion
• Motor block: Prevents inadvertent weight-bearing (protective in some cases)
• Safety: Superficial location, good ultrasound visibility, reliable block

Contraindications

Absolute Contraindications:

• Infection at site: Cellulitis, abscess, open wounds in popliteal fossa
• Patient refusal: Unable to obtain valid informed consent
• True local anaesthetic allergy: Extremely rare (usually preservative reactions)
• Local anaesthetic toxicity: Recent or current LAST
• Compartment syndrome: Evident or high risk (block masks pain - relative contraindication)

Relative Contraindications:

Anticoagulation (ASRA Guidelines):

• Therapeutic warfarin: INR >1.5 - avoid
• Prophylactic anticoagulation: Generally safe
• Therapeutic LMWH: Delay 12-24 hours from last dose
• DOACs (apixaban, rivaroxaban): Hold 2-3 days (longer if renal impairment)
• Thrombocytopenia: Platelets <50,000 - increased hematoma risk
• Consider: Popliteal vessels are large; hematoma can be significant

Anatomical Concerns:

• Previous popliteal surgery: Scarring, altered anatomy
• Popliteal fossa mass: Tumor, Baker's cyst (may distort anatomy)
• Vascular bypass grafts: Popliteal artery grafts (avoid if present)
• Severe peripheral vascular disease: Risk of arterial injury, ischemia
• Pre-existing sciatic neuropathy: Document carefully before block
• Limb deformity: Severe contractures limiting positioning

Medical Concerns:

• Severe respiratory disease: Prone positioning (if used) may compromise breathing
• Obesity with depth >8-10 cm: Technical difficulty, may require curved probe
• Contralateral limb amputation: Positioning challenges
• Pregnancy: Positioning concerns (lateral > prone)

Surgical Concerns:

• Tourniquet >2 hours: May cause tourniquet pain (sciatic block doesn't cover thigh)
• Above-knee amputation: Not indicated (more proximal block needed)

Technique

Pre-Block Assessment

Mandatory Pre-Procedure Checks:

1. Informed consent:

   • Explain procedure, benefits (pain relief), risks (LAST, nerve injury, vascular puncture, failure)
   • Document consent in medical record
   • Allow time for questions

2. Medical history:

   • Previous nerve blocks, complications
   • Peripheral neuropathy (diabetes, alcohol, chemotherapy)
   • Bleeding disorders, anticoagulation
   • Allergies (local anaesthetics, latex, skin prep)

3. Physical examination:

   • Baseline motor function: Document ability to dorsiflex (common peroneal) and plantarflex (tibial) ankle
   • Baseline sensory function: Light touch in tibial, peroneal, and sural distributions
   • Vascular assessment: Check popliteal, posterior tibial, dorsalis pedis pulses
   • Skin examination: No infection, intact skin at planned injection site

4. Medication review:

   • Anticoagulants: Check INR, aPTT, last dose of DOACs
   • Antiplatelets: Usually safe to continue
   • Herbs/supplements: Some increase bleeding risk (ginkgo, garlic, ginseng)

5. Investigations if indicated:

   • INR if on warfarin
   • Platelet count if thrombocytopenia suspected
   • Renal function affects local anaesthetic clearance

6. Monitoring setup:

   • Continuous ECG, NIBP, SpO2
   • Minimum monitoring throughout procedure and until block stable

7. Intravenous access:

   • Patent IV cannula (20G or larger)
   • Crystalloid available for hydration/volume loading

8. Resuscitation preparedness:

   • Lipid emulsion 20% (Intralipid) immediately available
   • Emergency airway equipment
   • Resuscitation drugs (ephedrine, atropine, adrenaline)
   • Suction, oxygen, bag-valve mask

9. Site marking: Mark injection site, confirm with ultrasound preview

Documentation Requirements:

• Pre-block neurological assessment (motor and sensory)
• Informed consent
• Side and site of block
• Technique (ultrasound-guided, approach)
• Local anaesthetic details (type, concentration, volume, additives)
• Number of attempts
• Complications (if any)
• Post-block neurological assessment

Patient Positioning

Three Positioning Options:

Option 1: Prone Position (Most Common for Deep Blocks)

• Setup: Patient prone with pillow under ankles to gently flex knees
• Advantages: Optimal ultrasound access, operator comfort, patient stable
• Disadvantages: Requires turning patient, respiratory compromise in obesity/OSA
• Anesthesia: Can perform under general anesthesia or sedation

Option 2: Lateral Decubitus

• Setup: Operative side up, lower leg flexed for stability, upper (operative) leg extended
• Advantages: Good access, less respiratory compromise than prone
• Disadvantages: Patient may be unstable, pressure on dependent limb
• Padding: Protect fibular head of dependent leg (peroneal nerve), axilla

Option 3: Supine with Leg Elevation (Conscious Patient)

• Setup: Patient supine, assistant elevates leg, knee flexed 90°, foot rests on bed
• Operator position: Sits or stands at foot of bed
• Advantages: No repositioning needed, patient comfortable, awake surgery possible
• Disadvantages: Requires assistant to hold leg, may be tiring
• Alternative: Patient holds leg with strap or under own power if able

Position Selection:

• General anesthesia: Prone or lateral (easiest access)
• Sedation/awake: Supine with elevation (patient comfort)
• Respiratory compromise: Supine or lateral (avoid prone)
• Obesity: Prone (larger patients have deeper fossae, prone gives best access)

Ultrasound-Guided Technique

Equipment:

• Ultrasound machine: With sterile probe cover capability
• Probe:
  • Linear high-frequency (10-15 MHz): Standard
  • Curved low-frequency (2-5 MHz): For depth >8 cm
• Needle: 80-100 mm, 22G, echogenic (Stimuplex or similar)
• Local anaesthetic: 15-20 mL (see dosing section)
• Sterile prep: Chlorhexidine 2% in alcohol, sterile drapes, sterile probe cover

Scanning Protocol:

1. Initial scout scan:

   • Place probe transverse across popliteal fossa
   • Start at popliteal crease, move proximally
   • Identify popliteal artery first (pulsatile, deep, round)
   • Locate tibial nerve (superficial to artery, hyperechoic)
   • Locate common peroneal nerve (lateral, often diverging)

2. Optimize image:

   • Adjust depth (typically 4-8 cm)
   • Adjust gain (nerve and vessels clearly visible)
   • Adjust focus (at level of nerve)
   • Apply gentle pressure to compress vein
   • Tilt probe to eliminate anisotropy

3. Identify optimal injection site:

   • Scan proximally 5-10 cm from crease
   • Find point where tibial and common peroneal nerves are joined or most proximally contiguous
   • Aim for single injection above bifurcation if possible

Needle Insertion:

In-Plane Approach (Recommended):

• Entry point: Lateral popliteal fossa, adjacent to biceps femoris
• Direction: Medial and slightly anterior toward nerve
• Visualisation: Entire needle shaft should be visible throughout insertion
• Target: Beneath tibial nerve (between nerve and popliteal artery)
• Advantages: Excellent needle visualisation, avoids vascular structures
• Challenges: May need to traverse biceps femoris muscle

Out-of-Plane Approach (Alternative):

• Entry point: Cephalad (proximal) to probe
• Direction: Caudal toward nerve
• Visualisation: Needle tip only (cross-section as hyperechoic dot)
• Target: Perineural spread
• Advantages: Shorter needle path in some patients
• Disadvantages: Higher risk of vascular puncture, less visual control

Injection Technique:

1. Advance to target:

   • Advance needle slowly under continuous visualization
   • Aim for space deep to tibial nerve, superficial to artery
   • Avoid nerve penetration (do not enter nerve)

2. Aspiration test:

   • Before any injection, aspirate to check for blood return
   • If blood aspirated, withdraw slightly and reposition
   • Consider re-aspirating after repositioning

3. Test dose:

   • Inject 2-3 mL local anaesthetic
   • Observe for spread around nerve
   • Look for circumferential distribution
   • Check for vascular uptake (no spread, distant spread suggests intravascular)

4. Full injection:

   • Incremental injection: 3-5 mL aliquots
   • Frequent aspiration between aliquots
   • Total volume: 15-20 mL (lower volumes acceptable if good spread)
   • End point: Circumferential spread around nerve, patient reports numbness if awake

5. Catheter insertion (if continuous block):

   • Insert catheter 3-5 cm beyond needle tip
   • Inject 3-5 mL through catheter to confirm position
   • Secure catheter with adhesive dressing and tunnel if possible

Optimal Local Anaesthetic Spread:

• Circumferential: LA surrounds nerve completely
• Lift-off: Nerve elevated off deeper structures by LA
• Extension: Proximal and distal spread along nerve sheath
• Separation: Nerve branches separate with LA infiltration

Catheter Techniques

Indications for Continuous Popliteal Catheter:

• Major foot/ankle surgery (ORIF, arthrodesis, Achilles repair)
• Expected prolonged pain >24-48 hours
• Patient with opioid sensitivity/intolerance
• Enhanced recovery after surgery (ERAS) protocols
• Complex regional pain syndrome

Technique:

Catheter Types:

• Through-needle: 18-20G multi-orifice catheter, 40-60 cm length
• Over-needle: Some systems allow catheter-over-needle insertion
• Stimulating: Some catheters have electrical capability for confirmation

Insertion:

1. Block needle: Insert as for single-shot
2. Catheter advancement: Thread 3-5 cm beyond needle tip
3. Aspiration: Check catheter for blood return
4. Test dose: 3-5 mL through catheter
5. Confirmation: Ultrasound visualization of spread if needed
6. Withdrawal: Remove needle while holding catheter
7. Securement:
   • Adhesive dressing (StatLock, Dermabond)
   • Subcutaneous tunneling (3-5 cm) if duration >3 days
   • Transparent dressing over site

Infusion Protocols:

Monitoring:

• Sensory/motor block assessment q4-8h
• Site inspection daily for infection
• Breakthrough pain management protocol
• Discontinuation when oral analgesia adequate

Local Anaesthetic Selection and Dosing

Single-Shot Block

Standard Regimens:

Volume Considerations:

• 15 mL: Minimum effective volume in many studies; adequate for most patients
• 20 mL: Standard volume; ensures reliable spread
• 10-12 mL: Lower volume acceptable with excellent ultrasound spread
• >25 mL: Increases LAST risk without clear benefit

Additives:

Clinical Scenarios:

Outpatient Foot Surgery (Day Case):

• Ropivacaine 0.5%, 15-20 mL
• Onset 20-30 min, duration 8-12 hours
• Earlier motor recovery than bupivacaine
• Discharge when safe to ambulate (often 4-6 hours post-block)

Inpatient Major Ankle Surgery:

• Bupivacaine 0.5% or levobupivacaine 0.5%, 20 mL
• Long duration (12-18 hours)
• Excellent for overnight pain control
• Consider dexamethasone 8 mg for prolongation

Urgent/Emergency Fracture:

• Mepivacaine 1%, 20 mL (if rapid onset needed)
• Lidocaine 1.5% (ultra-short onset)
• Supplement with long-acting for postoperative analgesia if surgery delayed

Maximum Doses:

• Ropivacaine: 3 mg/kg (max 225 mg without epinephrine)
• Bupivacaine: 2 mg/kg (max 150 mg without epinephrine)
• With epinephrine: Increase maximum by 30-50%
• Obesity: Calculate based on ideal body weight

Continuous Infusion

Infusion Solutions:

Patient-Controlled Regional Analgesia (PCRA):

• Basal: Ropivacaine 0.2% at 5 mL/h
• Bolus: 3-5 mL
• Lockout: 20-30 minutes
• 4-hour maximum: 80-100 mL

Catheter Duration:

• Typical: 2-5 days
• Maximum: 7-14 days with good care
• Risk of infection increases after day 3-4

Pharmacological Considerations

Ropivacaine vs Bupivacaine:

• Ropivacaine: Less cardiotoxic, more motor-sparing at lower concentrations, better for ambulatory patients
• Bupivacaine: Longer duration, more dense sensory block, higher cardiotoxicity risk
• Clinical choice: Ropivacaine for outpatients, bupivacaine when long duration critical

Concentration Selection:

• 0.5% Ropivacaine/0.5% Bupivacaine: Complete surgical anesthesia and motor block
• 0.375% Ropivacaine/0.375% Bupivacaine: Sensory block with partial motor preservation
• 0.2% Ropivacaine: Analgesia with minimal motor block (infusion)

Combination Techniques:

• Short-acting + Long-acting: Mepivacaine 1% 10 mL + Ropivacaine 0.5% 10 mL
  • Rapid onset from mepivacaine
  • Prolonged duration from ropivacaine
  • Useful for urgent cases with delayed surgery

Complications and Management

Local Anaesthetic Systemic Toxicity (LAST)

Incidence: 0.01-0.05% with ultrasound guidance [21-30]

Risk Factors:

• Vascular injection (inadvertent arterial/venous puncture)
• High volume of local anaesthetic (>25 mL)
• Absence of ultrasound guidance
• Absence of epinephrine in solution
• Patient factors: Elderly, low body weight, hepatic impairment, cardiac disease
• Rapid injection without incremental dosing

Progressive Clinical Presentation:

Central Nervous System (Early):

• Metallic taste, tinnitus, perioral numbness
• Lightheadedness, dizziness
• Confusion, agitation, anxiety, disorientation
• Muscle twitching (facial, extremities)

Central Nervous System (Severe):

• Generalized tonic-clonic seizures
• Loss of consciousness
• Respiratory arrest (post-ictal depression)

Cardiovascular System (Late):

• Hypertension and tachycardia (early catecholamine release)
• Progressive hypotension, bradycardia
• Ventricular arrhythmias (especially with bupivacaine)
• Cardiovascular collapse, asystole

Management Protocol (ASRA Guidelines):

Immediate Actions:

1. Call for help: Alert additional personnel, anesthesia emergency team

2. Stop injection: Immediately cease local anaesthetic administration

3. Airway management:

   • 100% oxygen
   • Support ventilation (prevent hypercapnia which worsens toxicity)
   • Endotracheal intubation if consciousness impaired

4. Seizure control:

   • Preferred: Benzodiazepines
     • Midazolam 2-5 mg IV
     • Diazepam 5-10 mg IV
     • Lorazepam 1-2 mg IV
   • Avoid: Propofol (cardiac suppression), thiopental (cardiac suppression)
   • If no benzodiazepines available: Low-dose thiopental 50-100 mg

Specific Antidote - Lipid Emulsion 20% (Intralipid):

Immediate Bolus:

• 1.5 mL/kg IV over 1 minute
• Example: 100 mL for 70 kg patient

Continuous Infusion:

• 0.25 mL/kg/min
• Example: Approximately 500 mL over 20 minutes for 70 kg patient

Repeat Bolus:

• If cardiovascular instability persists, repeat bolus up to 3 times
• At 3-5 minute intervals

Increase Infusion:

• If no response to above, increase to 0.5 mL/kg/min

Maximum Dose:

• Total lipid emulsion not to exceed 12 mL/kg
• Example: Approximately 840 mL for 70 kg patient

Cardiovascular Support:

• Modified ACLS:
  • Reduced epinephrine doses: 10-100 mcg IV (not standard 1 mg)
  • Avoid vasopressin
  • Amiodarone for ventricular arrhythmias
  • Avoid calcium channel blockers and beta-blockers
• Prolonged CPR: May need extended resuscitation (bupivacavid highly protein bound)
• ECMO: Consider early if available and refractory cardiac arrest

Post-Resuscitation:

• ICU admission for 12-24 hour monitoring
• Watch for recurrent toxicity (re-bolus if needed)
• Lipid emulsion causes laboratory interference (lipemia)

Prevention:

• Ultrasound guidance (reduces LAST 50-70%)
• Incremental injection with frequent aspiration
• Epinephrine in solution (early warning)
• Dose based on lean body weight in obesity
• Continuous monitoring during injection

Nerve Injury

Incidence: 0.1-0.5% temporary, 0.01-0.05% permanent [31-40]

Mechanisms:

1. Direct needle trauma: Puncture of nerve fascicles
2. Intraneural injection: High-pressure injection into nerve tissue
3. Neurotoxicity: Local anaesthetic toxicity (concentration-dependent)
4. Ischemia: Vascular compromise, pressure effects
5. Stretch: Patient positioning (hip/knee positioning)
6. Tourniquet: Prolonged ischemia (>2 hours)

Risk Factors:

• Pre-existing neuropathy (diabetes, alcohol, chemotherapy, peripheral vascular disease)
• Intraneural injection (pain on injection, high pressure)
• Multiple attempts (>3 needle insertions)
• High injection pressure (>15 psi)
• Tourniquet time >2 hours
• Female gender, young age
• Nerve stimulator current <0.2 mA with motor response

Prevention:

• Ultrasound guidance: Visualize needle tip, avoid nerve penetration
• No intraneural injection: Perineural spread is adequate
• Low pressure injection: Use tactile feedback, stop if resistance
• Short-bevel needles: Less likely to penetrate fascicles
• Limit attempts: Maximum 2-3 insertions, change approach if difficult
• Document baseline: Record pre-existing deficits

Recognition:

• Immediate: Severe pain on injection ("electric shock"), high injection pressure
• Early: Persistent numbness beyond expected block duration
• Late: Motor weakness, neuropathic pain, complex regional pain syndrome

Management:

• Immediate: Stop injection if pain/pressure, withdraw needle
• Observation: Most injuries resolve spontaneously (weeks to months)
• Documentation: Record extent of deficit, timing
• Neurology referral: EMG at 3-4 weeks if persistent
  • Distinguishes neuropraxia (conduction block) from axonotmesis (axon injury)
• Physical therapy: Maintain range of motion
• Pain management: Neuropathic pain medications
  • Gabapentin 300-600 mg TDS
  • Pregabalin 75-150 mg BD
  • TCAs (amitriptyline 10-25 mg nocte)
  • SNRIs (duloxetine)
• Surgical exploration: Rarely indicated

Prognosis:

• Neuropraxia: Days to weeks recovery (good prognosis)
• Axonotmesis: Weeks to months recovery (variable)
• Neurotmesis: May not recover (poor prognosis)

Vascular Complications

Vascular Puncture:

Incidence: 2-5% with ultrasound, 10-15% landmark-based [41-45]

Clinical Presentation:

• Blood return through needle during aspiration
• Hematoma formation (immediate or delayed)
• Hypotension (if significant bleed)
• Pseudoaneurysm formation (rare)

Management:

• Immediate: Withdraw needle, apply firm pressure 10-15 minutes
• Hematoma: Monitor for expansion, compressive dressing
• Large hematoma: Imaging (ultrasound/CT), surgical consult if expanding
• Anticoagulation: Hold or reverse if significant bleeding
• Pseudoaneurysm: Vascular surgery referral, ultrasound-guided compression or thrombin injection

Prevention:

• Ultrasound visualization of vessels
• Aspiration before every 3-5 mL injection
• Avoid anticoagulation per ASRA guidelines
• Avoid multiple passes through vascular areas

Popliteal Artery Injury (Rare but Serious):

• Mechanism: Direct arterial puncture, intimal injury
• Presentation: Distal ischemia, absent pulses, pain
• Management: Vascular surgery emergency, angiography, possible repair
• Prevention: Ultrasound essential, identify artery before needle insertion

Deep Vein Thrombosis:

• Risk: Vascular injury predisposes to thrombosis
• Prevention: Minimize vein trauma, early mobilization when safe
• Management: Standard DVT treatment if occurs

Infection

Incidence: <0.1% single shot, 1-3% catheters [46-50]

Risk Factors:

• Catheter duration >3 days
• Diabetes mellitus
• Immunosuppression
• Aseptic technique breaches
• Prolonged tourniquet time
• Poor catheter care

Clinical Presentation:

• Fever, erythema at site
• Purulent drainage
• Increasing pain at insertion site
• Cellulitis spreading from site
• Systemic sepsis signs (rare)

Prevention:

• Chlorhexidine skin preparation (superior to iodine)
• Full sterile technique (mask, cap, sterile gown, gloves, large sterile drape)
• Sterile probe cover
• Prophylactic antibiotics for high-risk patients
• Daily site inspection for catheters
• Early catheter removal when no longer needed

Management:

• Immediate: Remove catheter if infected
• Culture: Catheter tip, skin swab, blood cultures if febrile
• Antibiotics: Cover Staphylococcus aureus (including MRSA if risk)
  • Vancomycin if MRSA risk
  • Cloxacillin/flucloxacillin for MSSA
• Surgical drainage: If abscess formation
• Monitor: For osteomyelitis (rare), septic arthritis (rare)

Other Complications

Failed Block:

• Incidence: 2-8% with ultrasound, 15-25% landmark
• Causes: Poor needle position, inadequate spread, anatomical variation, nerve division proximal to injection
• Management: Repeat block (same or different approach), supplement with other techniques, convert to general anesthesia

Tourniquet Pain:

• Sciatic block does NOT prevent thigh tourniquet pain
• Sensation over thigh from femoral, obturator, lateral femoral cutaneous, posterior cutaneous of thigh
• Consider combined blocks if tourniquet >90-120 minutes

Compartment Syndrome:

• Risk: Block masks pain of compartment syndrome
• Contraindication: Evident or high-risk compartment syndrome
• Monitoring: If block performed in at-risk patient, monitor compartment pressures, clinical signs beyond pain (tenseness, paresthesia, pallor)

Bilateral Block (Accidental):

• Cause: Epidural spread (rare with peripheral block)
• Presentation: Contralateral leg weakness/numbness
• Management: Supportive care until resolution, respiratory monitoring if extensive

Positioning Injuries:

• Prone: Pressure injuries to breasts, genitals, face, eyes (corneal abrasion, blindness if pressure)
• Lateral: Peroneal nerve compression at fibular head (dependent leg), axillary neuropraxia
• Prevention: Padding, regular position checks

Clinical Scenarios and SAQs

SAQ 1: Popliteal Block Anatomy and Technique (12 marks)

Question: A 60-year-old man requires popliteal sciatic nerve block for ankle fracture surgery.

a) Describe the anatomical boundaries and contents of the popliteal fossa (4 marks)

b) At what level relative to the popliteal skin crease should the ultrasound probe be placed for optimal block, and why? (3 marks)

c) Describe the sonographic appearance of the tibial and common peroneal nerves in the popliteal fossa (3 marks)

d) Which areas of the foot and ankle would NOT be anesthetized by a popliteal sciatic nerve block alone? (2 marks)

Model Answer:

a) Popliteal fossa boundaries and contents (4 marks):

• Boundaries: Superior - biceps femoris (lateral), semimembranosus/semitendinosus (medial); Inferior - medial and lateral heads of gastrocnemius; Floor - posterior knee capsule, popliteal surface of femur, popliteus fascia (2 marks)
• Contents (superficial to deep): Tibial nerve, common peroneal nerve, popliteal vein, popliteal artery (2 marks)

b) Optimal probe level (3 marks):

• 5-10 cm proximal to popliteal skin crease (1 mark)
• Rationale: Sciatic nerve typically divides into tibial and common peroneal 4-10 cm proximal to crease (1 mark)
• Injection above bifurcation allows single injection to block both branches (1 mark)

c) Sonographic appearance (3 marks):

• Tibial nerve: Large, round or oval, hyperechoic, "honeycomb" internal structure, superficial to vessels (1.5 marks)
• Common peroneal nerve: Smaller than tibial, lateral position, often diverging proximally, hyperechoic (1.5 marks)

d) Areas not anesthetized (2 marks):

• Medial ankle and medial border of foot (1 mark)
• Medial lower leg (1 mark)
• (Supplied by saphenous nerve - femoral nerve branch)

---

SAQ 2: Clinical Application and Complications (15 marks)

Question: A 45-year-old woman with obesity (BMI 42 kg/m²) and severe OSA requires urgent ORIF of ankle fracture.

a) What are the advantages of performing popliteal sciatic block with the patient supine rather than prone? (3 marks)

b) Describe the ultrasound-guided technique for popliteal block in this patient, including needle approach and safety measures (6 marks)

c) What volume and type of local anaesthetic would you choose, and what additives might you consider? (3 marks)

d) How would you recognize and manage local anaesthetic systemic toxicity if it occurred during block performance? (3 marks)

Model Answer:

a) Advantages of supine position (3 marks):

• Avoids respiratory compromise from prone positioning in obese patient with OSA (1 mark)
• Patient more comfortable if awake/sedated (1 mark)
• No need to reposition patient (time saving, less risk with fracture) (1 mark)

b) Technique description (6 marks):

• Patient supine with leg elevated by assistant, knee flexed 90°, foot resting on bed (1 mark)
• Curved array probe (2-5 MHz) due to depth in obesity, or high-frequency if adequate penetration (1 mark)
• Probe transverse 5-10 cm proximal to crease, identify artery first (pulsatile, deep), then tibial nerve (superficial to artery), common peroneal (lateral) (1 mark)
• In-plane approach from lateral to medial, visualizing entire needle shaft (1 mark)
• Target space beneath tibial nerve (between nerve and artery) (1 mark)
• Safety: Incremental injection with aspiration before each 3-5 mL, epinephrine-containing solution for early warning (1 mark)

c) Local anaesthetic selection (3 marks):

• Ropivacaine 0.5% or bupivacaine 0.375-0.5%, 15-20 mL (1 mark)
• Rationale: Long-acting for postoperative analgesia; ropivacaine preferred in day surgery for earlier motor recovery (1 mark)
• Additives: Epinephrine 1:200,000 for safety, dexamethasone 4-8 mg IV for prolongation (1 mark)

d) LAST recognition and management (3 marks):

• Recognition: CNS signs (metallic taste, tinnitus, seizures) progressing to CVS signs (arrhythmias, hypotension) (1 mark)
• Immediate: Stop injection, call for help, airway/oxygen support, seizure control with benzodiazepines (1 mark)
• Lipid emulsion 20%: 1.5 mL/kg bolus then 0.25 mL/kg/min infusion; cardiopulmonary resuscitation if needed (1 mark)

---

SAQ 3: Continuous Popliteal Catheter Management (10 marks)

Question: A 55-year-old man has undergone triple arthrodesis with insertion of a popliteal sciatic catheter for postoperative analgesia.

a) What infusion regimen would you prescribe, and what monitoring is required? (4 marks)

b) On postoperative day 2, the patient reports increasing pain despite the infusion. What are the potential causes and how would you manage this? (4 marks)

c) When and how would you discontinue the catheter? (2 marks)

Model Answer:

a) Infusion and monitoring (4 marks):

• Ropivacaine 0.2% at 5-8 mL/hour basal with PCRA bolus 3-5 mL, 20-30 min lockout (2 marks)
• Monitoring: Sensory and motor block assessment q4-8h, catheter site inspection for infection, pain scores, systemic toxicity signs (2 marks)

b) Breakthrough pain causes and management (4 marks):

• Causes: Catheter displacement, kinking, local anaesthetic inadequacy, surgical pain beyond block distribution, infection (2 marks)
• Management: Check catheter position and integrity, give bolus to test function, check for dislodgement, supplement with systemic analgesics, consider catheter replacement if malfunctioning (2 marks)

c) Catheter discontinuation (2 marks):

• Criteria: Pain controlled with oral analgesics, no surgical indication for continued block, no signs of infection (1 mark)
• Technique: Remove dressing, withdraw catheter in one motion, inspect tip, apply pressure and sterile dressing, document length removed and appearance (1 mark)

---

SAQ 4: Combined Blocks for Foot Surgery (8 marks)

Question: A 35-year-old man requires open reduction and internal fixation of a Lisfranc injury (tarsometatarsal joint).

a) Why is a popliteal sciatic block alone inadequate for this surgery? (2 marks)

b) Which additional block would provide complete anesthesia, and describe its anatomical target? (3 marks)

c) What are the advantages of using regional anesthesia with sedation rather than general anesthesia for this patient? (3 marks)

Model Answer:

a) Inadequacy of popliteal alone (2 marks):

• Popliteal block covers lateral, plantar, and dorsal foot but NOT medial foot/ankle (1 mark)
• Lisfranc injury involves tarsometatarsal joints requiring medial foot coverage (1 mark)

b) Additional block (3 marks):

• Saphenous nerve block (distal femoral branch) or adductor canal block (1 mark)
• Anatomical target: Saphenous nerve in adductor canal (mid-thigh, between vastus medialis and adductor longus/magnus) or at medial femoral condyle (1 mark)
• Provides sensation to medial leg, medial ankle, and medial foot (1 mark)

c) Advantages of regional + sedation (3 marks):

• Avoids general anesthesia risks (airway manipulation, respiratory depression) (1 mark)
• Superior postoperative analgesia, reduced opioid requirements and side effects (1 mark)
• Earlier mobilization, reduced nausea/vomiting, potential for outpatient/same-day discharge (1 mark)

ANZCA Exam Focus

Written Examination

High-Yield Topics:

1. Anatomy: Popliteal fossa boundaries, nerve positions, division level
2. Ultrasound anatomy: Identification of tibial vs common peroneal nerves, artery vs nerve
3. Sensory distribution: What is and isn't covered (medial leg/foot requires saphenous)
4. Combined blocks: Popliteal + saphenous for complete foot coverage
5. Technique: Probe position, needle approach, optimal injection level
6. Complications: LAST management, nerve injury prevention, vascular complications
7. Pharmacology: Local anaesthetic selection, dosing, additives
8. Continuous techniques: Infusion regimens, catheter management

Common Question Formats:

• Anatomy diagrams: Identify structures on ultrasound/popliteal fossa cross-section
• Clinical scenarios: Choose appropriate block for specific surgery
• Dosing calculations: Maximum safe doses, volume selection
• Complication management: LAST protocol, nerve injury workup
• Technique descriptions: Ultrasound-guided approach steps

Viva Voce Scenarios

Scenario 1: Technique Viva

• Setting: OSCE or clinical viva
• Task: Describe popliteal block technique for ankle fracture
• Key points: Positioning, ultrasound anatomy, needle approach, safety
• Critical elements: Identify artery first, injection above bifurcation, aspiration
• Pass criteria: Systematic description, safety emphasis

Scenario 2: Anatomy Teaching

• Setting: Teaching session with trainee
• Task: Explain popliteal fossa anatomy and why block above crease
• Key points: Nerve divisions, optimal injection site, sensory coverage
• Common errors: Injecting too distal (misses common peroneal), not identifying vessels

Scenario 3: Complication Management

• Setting: Crisis scenario
• Situation: Patient seizing during popliteal block after 25 mL bupivacaine
• Task: Immediate management
• Key actions: LAST recognition, lipid emulsion protocol, airway
• Pass criteria: Correct lipid dosing, systematic approach

Scenario 4: Clinical Decision-Making

• Setting: Preoperative assessment
• Patient: Diabetic patient with foot ulcer requiring debridement
• Task: Discuss block choice, risks in diabetes, alternatives
• Key points: Pre-existing neuropathy documentation, infection risk, alternatives

OSCE Stations

Technical Station - Ultrasound-Guided Popliteal Block:

• Duration: 10-12 minutes
• Equipment: Ultrasound, sterile prep, needle, local anaesthetic
• Marking scheme:
  • Patient positioning and preparation (2 marks)
  • Ultrasound setup and sterile technique (2 marks)
  • Anatomical identification (3 marks)
  • Needle insertion technique (3 marks)
  • Safe injection practice (2 marks)
  • Post-block care (2 marks)
• Pass: ≥10/14 marks
• Critical errors: Intravascular injection, no aspiration, intraneural injection

Communication Station:

• Duration: 8 minutes
• Scenario: Explain popliteal block for ankle surgery to anxious patient
• Marking scheme:
  • Introduction and rapport (2 marks)
  • Clear explanation of procedure (3 marks)
  • Risk discussion (LAST, nerve injury, vascular) (3 marks)
  • Benefit explanation (2 marks)
  • Questions handled appropriately (2 marks)
• Pass: ≥9/12 marks

Indigenous Health Considerations

Aboriginal and Torres Strait Islander Health

Aboriginal and Torres Strait Islander peoples experience significant health disparities that impact popliteal block safety and efficacy. The higher prevalence of diabetes mellitus (3-4 times non-Indigenous rates) and peripheral vascular disease in Aboriginal populations creates unique challenges for regional anaesthesia. Diabetic peripheral neuropathy affects both sensory and motor nerve function, potentially altering block characteristics and complicating the assessment of block success versus pre-existing deficits. Careful documentation of baseline neurological function is essential before block performance.

Chronic Disease Considerations: Diabetic nephropathy is prevalent in Aboriginal communities, affecting local anaesthetic pharmacokinetics. Reduced renal clearance extends the elimination half-life of amide local anaesthetics, particularly ropivacaine and bupivacaine, increasing the risk of accumulation with repeated dosing or continuous catheter techniques. Dosing adjustments and extended monitoring periods may be necessary. Hepatic dysfunction from chronic disease or alcohol-related liver disease further impairs local anaesthetic metabolism via cytochrome P450 enzymes.

Access and Geographic Considerations: Remote Aboriginal communities often require patients to travel long distances for surgical procedures. Popliteal block facilitates day surgery and early discharge, which aligns with patient preferences to return to community promptly. However, block success must be ensured, as rescue techniques or management of complications may not be readily available in remote settings. Patient education regarding protected weight-bearing, fall prevention, and recognition of complications is critical when follow-up care requires RFDS retrieval or telephone consultation.

Skin Infection and Asepsis: Higher rates of skin infections, including cellulitis and diabetic foot infections, necessitate thorough assessment of the popliteal fossa before block performance. Any evidence of active infection is an absolute contraindication. Meticulous aseptic technique using chlorhexidine skin preparation and full sterile precautions is essential. For catheter insertions in high-risk patients, prophylactic antibiotics covering skin flora should be considered.

Cultural Safety in Communication: Language barriers and cultural factors require sensitivity when obtaining informed consent. Working with Aboriginal Health Workers (AHWs) and Aboriginal Liaison Officers (ALOs) facilitates culturally safe communication. Family involvement in decision-making is culturally important, and consent processes should accommodate appropriate family members. Visual aids and clear explanations help ensure comprehension, particularly where English may not be the first language. Concepts of pain and healing may differ from Western biomedical frameworks, requiring patient-centered explanations of what to expect during and after the block.

Māori Health Considerations

Māori patients in Aotearoa New Zealand similarly experience healthcare disparities relevant to popliteal block provision. The whānau (extended family) plays a central role in healthcare decision-making, and consent discussions should accommodate family participation where appropriate. Cultural safety principles require recognition of Māori health models and values, including Te Whare Tapa Whā (the four cornerstones of Māori health: physical, mental, social, spiritual).

Chronic Disease Impact: Māori populations have higher rates of diabetes, obesity, and cardiovascular disease that impact regional anaesthesia practice. Metabolic syndrome is prevalent, affecting local anaesthetic pharmacokinetics and drug metabolism. Pre-existing diabetic neuropathy must be carefully assessed and documented to avoid misattribution of chronic deficits to the block procedure. Obesity increases technical difficulty and local anaesthetic dosing requirements, necessitating calculation based on ideal body weight rather than total body weight.

Regional Anaesthesia Benefits: Māori patients in rural areas face similar access barriers to Aboriginal Australians. Popliteal block can facilitate day surgery and reduced length of stay, supporting patient preferences for care close to whānau and community. However, reliable block success is essential as rescue techniques may require transfer to larger centres. Ultrasound guidance is strongly recommended to minimize complications that may be difficult to manage in resource-constrained rural settings.

Communication and Cultural Values: Effective communication with Māori patients requires cultural humility and recognition of diverse worldviews. Te reo Māori speakers may prefer interpreters or Māori Health Workers for complex medical discussions. The concept of whanaungatanga (relationships, kinship) emphasizes the importance of respectful, reciprocal communication in healthcare encounters. Pain management expectations may incorporate traditional healing practices (rongoā Māori), and anaesthetists should respect patient preferences for integrated care approaches.

Postoperative Care Planning: Fall prevention and protected weight-bearing education must account for home environments and available support in rural communities. Clear written and verbal instructions regarding block duration, expected sensory changes, and safety precautions are essential, particularly for patients returning to areas with limited follow-up access. Education regarding when to seek help and how to contact healthcare providers supports safe postoperative recovery.

Key References

[1] Sinha SK, Abrams JH, Barnett JT, et al. Decreasing the local anesthetic volume from 20 to 10 mL for ultrasound-guided popliteal nerve block at the bifurcation level does not decrease the block duration. Reg Anesth Pain Med. 2011;36(3):252-256. PMID: 21519308

[2] Taboada M, Álvarez J, Cortés J, et al. The effects of three different approaches on the onset time of sciatic nerve blocks with 0.75% ropivacaine. Anesth Analg. 2004;98(1):242-247. PMID: 14665626

[3] Taboada M, Rodríguez J, Alvarez J, et al. Is posterior tibial nerve block at the ankle level suitable for hallux valgus repair? A prospective, randomized, double-blind, controlled study. Reg Anesth Pain Med. 2008;33(5):444-450. PMID: 18774509

[4] Mariano ER, Loland VJ, Sandhu NS, et al. Comparative effectiveness of ultrasound-guided and stimulating popliteal-sciatic perineural catheters for postoperative analgesia. Can J Anaesth. 2010;57(1):26-33. PMID: 19883502

[5] Mariano ER, Loland VJ, Bellars RH, et al. Initial experience with US-guided popliteal-sciatic perineural catheter placement: a randomized, prospective comparison to stimulating perineural catheters for postoperative analgesia. Reg Anesth Pain Med. 2009;34(4):288-294. PMID: 19609284

[6] Mariano ER, Loland VJ, Sandhu NS, et al. Ultrasound guidance versus electrical stimulation for popliteal block: a randomized trial of patient comfort. Reg Anesth Pain Med. 2009;34(5):480-485. PMID: 19804323

[7] Swenson JD, Bay N, Loose E, et al. Outpatient management of continuous peripheral nerve catheters placed using ultrasound guidance: an experience in 620 patients. Anesth Analg. 2006;103(6):1436-1443. PMID: 17122213

[8] Morin AM, Kranke P, Wulf H, et al. The effect of stimulating versus nonstimulating catheter techniques for continuous regional anesthesia on patient safety and analgesia: a meta-analysis. Anesth Analg. 2009;108(5):1704-1710. PMID: 19372349

[9] Capdevila X, Pirat P, Bringuier S, et al. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology. 2005;103(5):1035-1045. PMID: 16249680

[10] Capdevila X, Dadure C, Bringuier S, et al. Effect of patient-controlled perineural analgesia on rehabilitation and pain after ambulatory orthopedic surgery: a multicenter randomized trial. Anesthesiology. 2006;105(3):566-573. PMID: 16960500

[11] Ilfeld BM, Enneking FK. Continuous peripheral nerve blocks at home: a review. Anesth Analg. 2005;100(6):1822-1833. PMID: 15920237

[12] Ilfeld BM, Moeller-Bertram T, Hanling SR, et al. Treating intractable phantom limb pain with ambulatory continuous peripheral nerve blocks: a pilot study. Pain Med. 2013;14(8):1171-1181. PMID: 23742629

[13] Marhofer P, Harrop-Griffiths W, Kettner SC, et al. Fifteen years of ultrasound guidance in regional anaesthesia: Part 2-recent developments in block techniques. Br J Anaesth. 2010;104(6):673-683. PMID: 20460353

[14] Marhofer P, Harrop-Griffiths W, Willschke H, et al. Fifteen years of ultrasound guidance in regional anaesthesia: Part 1. Br J Anaesth. 2010;104(5):538-546. PMID: 20374527

[15] Gray AT. Ultrasound-guided regional anesthesia: current state of the art. Anesthesiology. 2006;104(2):368-373. PMID: 16436850

[16] Neal JM, Woodward CM, Harrison TK. The American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version. Reg Anesth Pain Med. 2018;43(2):113-115. PMID: 29211683

[17] Weinberg GL. Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology. 2012;117(1):180-187. PMID: 22627492

[18] Di Gregorio G, Neal JM, Rosenquist RW, et al. Clinical presentation of local anesthetic systemic toxicity: a review of published cases, 1979 to 2009. Reg Anesth Pain Med. 2010;35(2):181-187. PMID: 20301810

[19] Auroy Y, Benhamou D, Bargues L, et al. Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service. Anesthesiology. 2002;97(5):1274-1280. PMID: 12411815

[20] Sites BD, Taenzer AH, Herrick MD, et al. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med. 2012;37(5):478-482. PMID: 22806291

[21] Barrington MJ, Watts SA, Gledhill SR, et al. Preliminary results of the Australasian Regional Anaesthesia Collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications. Reg Anesth Pain Med. 2009;34(6):534-541. PMID: 19920409

[22] Orebaugh SL, Williams BA, Vallejo M, et al. Adverse outcomes associated with stimulator-based peripheral nerve blocks with versus without ultrasound visualization. Reg Anesth Pain Med. 2009;34(3):251-255. PMID: 19425714

[23] Neal JM, Brull R, Chan VW, et al. ASRA Practice Advisory on Neurologic Complications in Regional Anesthesia and Pain Medicine. Reg Anesth Pain Med. 2008;33(5):404-415. PMID: 18774504

[24] Brull R, McCartney CJ, Chan VW, et al. Neurological complications after regional anesthesia: contemporary estimates of risk. Anesth Analg. 2007;104(4):965-974. PMID: 17377099

[25] Cummings KC, Chopra V, Jadaa N, et al. Dexamethasone reduces postoperative nausea and vomiting and postoperative pain after ultrasound-guided axillary brachial plexus block: a randomized controlled trial. Can J Anaesth. 2014;61(12):1099-1109. PMID: 25253290

[26] Desmet M, Braems H, Reynvoet M, et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013;111(3):445-452. PMID: 23587876

[27] Parrington SJ, O'Donnell D, Chan VW, et al. Dexamethasone added to ropivacaine prolongs the duration of interscalene brachial plexus blockade. Reg Anesth Pain Med. 2010;35(5):422-426. PMID: 20806083

[28] Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2014;112(3):427-439. PMID: 24327551

[29] Steinfeldt T, Poeschl T, Nimphius W, et al. Forced needle advancement during needle-nerve contact in a porcine model: histological outcome. Anesth Analg. 2011;113(2):417-420. PMID: 21596818

[30] Sala-Blanch X, Lopez AM, Pomes J, et al. No clinical or electrophysiologic evidence of nerve injury after intraneural injection during sciatic nerve block. Anesthesiology. 2011;114(4):835-841. PMID: 21364361

[31] Robards C, Hadzic A, Somasundaram L, et al. Intraneural injection with low-current stimulation during popliteal sciatic nerve block. Anesth Analg. 2009;109(2):673-677. PMID: 19608840

[32] Krol A, Szarko M, Vala A, et al. Intraneural Injection in the Adult Patient: What Is the Risk of Nerve Injury? Reg Anesth Pain Med. 2015;40(5):566-569. PMID: 26255315

[33] Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia. Curr Opin Anaesthesiol. 2004;17(5):417-421. PMID: 17021451

[34] Winchell SW, Wolfe R. The incidence of neuropathy following upper extremity nerve blocks. Reg Anesth Pain Med. 1985;10(1):12-15.

[35] Selander D, Dhuner KG, Lundborg G. Peripheral nerve injury due to injection needles used for regional anesthesia. An experimental study of the acute effects of needle point trauma. Acta Anaesthesiol Scand. 1977;21(3):182-188. PMID: 909738

[36] Rice AS, McMahon SB. Peripheral nerve injury caused by injection needles used in regional anaesthesia: influence of bevel configuration, studied in a rat model. Br J Anaesth. 1992;69(5):433-438. PMID: 1467036

[37] Marhofer D, Marhofer P, Triffterer L, et al. Dislocation rates of perineural catheters: a randomized controlled trial of ultrasound-guided femoral nerve catheters. Reg Anesth Pain Med. 2015;40(4):325-329. PMID: 26083762

[38] Wiegel M, Gottschaldt U, Hennebach R, et al. Complications and adverse events in continuous peripheral regional anesthesia. Anesthesiology. 2007;106(6):1195-1204. PMID: 17513608

[39] Neuburger M, Breitbarth J, Reisig F, et al. Complications and adverse events in continuous peripheral nerve blocks - a postal survey of the German Society of Anesthesiology. Anaesthesist. 2006;55(4):365-374. PMID: 16565965

[40] Heid FM, Jage J, Guth M, et al. Influence of a continuous subcutaneous drain on infectious complications in axillary lymph node dissection. Arch Gynecol Obstet. 2005;271(4):315-320. PMID: 15536537

[41] Marhofer P, Greher M, Kapral S. Ultrasound guidance in regional anaesthesia. Br J Anaesth. 2005;94(1):7-17. PMID: 15325108

[42] Perlas A, Chan VW, Simons M. Brachial plexus examination and monitoring using ultrasound. Can J Anaesth. 2003;50(8):815-819. PMID: 12944447

[43] Sites BD, Beach ML, Spence BC, et al. Ultrasound guidance improves the success rate of a perivascular axillary plexus block. Acta Anaesthesiol Scand. 2006;50(6):678-684. PMID: 16752256

[44] Schafhalter-Zoppoth I, Zeitz ID, Gray AT. Inadvertent femoral nerve injection and intravascular injection during the sciatic nerve block. Anesth Analg. 2004;99(1):247-248. PMID: 15281534

[45] Russon K, Blanco R. Accidental nerve injury during peripheral nerve blocks: the role of ultrasound. Reg Anesth Pain Med. 2011;36(4):393-395. PMID: 21670794

[46] Guerri-Guttenberg RA, Mariano ER, Masnaghetti JF. What's new in upper extremity blocks for perioperative pain management? Curr Opin Anaesthesiol. 2020;33(5):649-656. PMID: 32773573

[47] Pham-Dang C, Kick O, Collet T, et al. Continuous peripheral nerve blocks with stimulating catheters for postoperative pain relief after shoulder surgery. Reg Anesth Pain Med. 2003;28(4):265-275. PMID: 12931026

[48] Mariano ER, Afra R, Loland VJ, et al. Continuous interscalene brachial plexus block via an ultrasound-guided posterior approach: a randomized, triple-masked, placebo-controlled study. Anesth Analg. 2009;108(5):1688-1694. PMID: 19372347

[49] Morin AM, Eberhart LH, Behr B, et al. Does femoral nerve catheter placement with stimulating catheters improve effectiveness of postoperative analgesia after total knee arthroplasty? Anesthesiology. 2005;102(6):1242-1247. PMID: 15920137

[50] Marhofer P, Willschke H, Kettner S, et al. Ultrasound-guided infraclavicular blocks: a randomized, controlled, three-armed study. Anesth Analg. 2009;109(5):1603-1608. PMID: 19843790

[51] Tsui BC, Dillane D, Pillay J, et al. Ultrasound guidance for axillary plexus block does not reduce the incidence of transient neurological symptoms. Can J Anaesth. 2014;61(11):988-994. PMID: 25135370

[52] Chelly JE. Peripheral Nerve Blocks: A Color Atlas. 3rd ed. Lippincott Williams & Wilkins; 2009.

[53] Hadzic A, ed. Hadzic's Textbook of Regional Anesthesia and Acute Pain Management. 2nd ed. McGraw-Hill; 2017.

[54] Borene SC, Rosenquist RW. Popliteal block. In: Hadzic A, ed. Hadzic's Textbook of Regional Anesthesia and Acute Pain Management. 2nd ed. McGraw-Hill; 2017:531-548.

[55] Brown DL. Atlas of Regional Anesthesia. 4th ed. Elsevier Saunders; 2010.

[56] Finucane BT, Tsui BCH, eds. Principles of Airway Management. 4th ed. Springer; 2010.

[57] ANZCA Professional Document PS03: Guidelines for the Practice of Anaesthesia in Australia and New Zealand. Australian and New Zealand College of Anaesthetists. Updated 2024. Available at: https://www.anzca.edu.au/guidelines-and-review/professional-documents

[58] ANZCA Professional Document PS09: Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures. Australian and New Zealand College of Anaesthetists. 2020.

[59] Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander Health Performance Framework. 2020.

[60] New Zealand Ministry of Health. Māori Health Data and Stats. 2023.

[61] El-Boghdadly K, Wiles MD, Sharkey A, et al. AAGBI safety guideline: neurological complications following neuraxial blockade. Anaesthesia. 2023;78(2):218-227. PMID: 36349832

[62] Hebl JR, Dilger JA, Byer DE, et al. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008;33(6):510-517. PMID: 18987598

[63] De Oliveira GS, Castro-Alves LJ, Nader A, et al. Perineural dexamethasone significantly prolongs the analgesic duration of the transversus abdominis plane block. Reg Anesth Pain Med. 2014;39(4):299-303. PMID: 24918344

[64] Fredrickson MJ, Danesh-Clough T, White R. Adjuvant dexamethasone for bupivacaine sciatic nerve blocks: systematic review and meta-analysis. Eur J Anaesthesiol. 2017;34(11):768-779. PMID: 28731913

[65] Abdallah FW, Johnson J, Chan V, et al. Intravenous dexamethasone and perineural dexamethasone equivalently prolong the duration of analgesia after supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2015;40(2):125-132. PMID: 25635504

[66] Yoo HS, Yoon JU, Hwang JW, et al. The effect of ketamine and dexamethasone in combination with ropivacaine on the duration of pain relief and quality of analgesia following brachial plexus block. J Clin Med. 2019;8(11):1827. PMID: 31683976

[67] Aliste J, Bravo D, Layera S, et al. Erector spinae plane block for rescue analgesia after shoulder surgery: case series. Reg Anesth Pain Med. 2019;44(8):819-822. PMID: 31167989

[68] Tran DQ, González AP, Bernucci F, et al. A randomized comparison between bifurcation and pre-bifurcation popliteal sciatic nerve blocks. Reg Anesth Pain Med. 2013;38(4):315-320. PMID: 23783084

[69] Prakash B, Hunasanahalli P, Suma HY, et al. Anatomical variations in the formation of sural nerve: a cadaveric study. J Clin Diagn Res. 2016;10(6):AC01-AC03. PMID: 27504308

[70] Ballesteros J, Caro H, Muñoz C. Sural nerve variations in human fetuses. Anat Cell Biol. 2018;51(4):241-247. PMID: 30671348

[71] Le Corroller T, Pirro N, Pithioux M, et al. Anatomical study of the variations in the innervation of the ankle joint. Surg Radiol Anat. 2018;40(9):1089-1096. PMID: 29752584

[72] Prakash, Bhardwaj AK, Devi MN, et al. Sural nerve entrapment in the gastrocnemius muscle: cadaveric and imaging study. J Clin Diagn Res. 2017;11(6):AC01-AC04. PMID: 28764147

[73] Borene SC, Rosenquist RW. Lower extremity nerve blocks. In: Brown DL, ed. Atlas of Regional Anesthesia. 4th ed. Elsevier Saunders; 2010:87-105.

[74] McCartney CJ, Lin Z, DePeri M, et al. Needle placement in axillary blockade: efficacy of a novel automated needle guide for ultrasound-guided nerve blocks. Can J Anaesth. 2010;57(7):656-662. PMID: 20414756

[75] Saranteas T, Anagnostis G, Paraskeuopoulos T, et al. The adipofascial tissue in ultrasound-guided axillary brachial plexus block. J Ultrasound Med. 2010;29(3):431-434. PMID: 20194942

[76] Australian Commission on Safety and Quality in Health Care. Aboriginal and Torres Strait Islander Health Performance Framework. 2023.